Jolien F. Van Nimwegen

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Lacrimal gland ultrasonography shows superior reliability of OMERACT colour Doppler scoring compared to B-mode, in patients with clinically suspected Sjögren's disease.

Lacrimal gland ultrasonography shows superior reliability of OMERACT colour Doppler scoring compared to B-mode, in patients with clinically suspected Sjögren's disease.

Journal: Scandinavian journal of rheumatology

Published: September 09, 2025

Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren's disease.

Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren's disease.

Journal: RMD open

Published: July 11, 2024

Increased Interferon Signaling in Vaginal Tissue of Patients With Primary Sjögren Syndrome.

Increased Interferon Signaling in Vaginal Tissue of Patients With Primary Sjögren Syndrome.

Journal: The Journal of rheumatology

Published: March 21, 2024

Can ultrasound of the major salivary glands differentiate Sjögren's disease from its major mimics?

Can ultrasound of the major salivary glands differentiate Sjögren's disease from its major mimics?

Journal: Clinical and experimental rheumatology

Published: July 21, 2023

Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included.

Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 22, 2023

Patient Acceptable Symptom State (PASS) in patients with primary Sjögren's syndrome in daily clinical practice.

Patient Acceptable Symptom State (PASS) in patients with primary Sjögren's syndrome in daily clinical practice.

Journal: Clinical and experimental rheumatology

Published: June 20, 2022

Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial.

Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial.

Journal: Seminars in arthritis and rheumatism

Published: September 24, 2021

Clinical determinants of vaginal dryness in patients with primary Sjögren's syndrome.

Clinical determinants of vaginal dryness in patients with primary Sjögren's syndrome.

Journal: Clinical and experimental rheumatology

Published: June 14, 2021

Histopathology, salivary flow and ultrasonography of the parotid gland: three complementary measurements in primary Sjögren's syndrome.

Histopathology, salivary flow and ultrasonography of the parotid gland: three complementary measurements in primary Sjögren's syndrome.

Journal: Rheumatology (Oxford, England)

Published: June 14, 2021

Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure.

Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure.

Journal: The Lancet. Rheumatology

Published: February 12, 2021

Clinical Phenotyping of Primary Sjögren Syndrome Patients Using Salivary Gland Ultrasonography: Data From the RESULT Cohort.

Clinical Phenotyping of Primary Sjögren Syndrome Patients Using Salivary Gland Ultrasonography: Data From the RESULT Cohort.

Journal: The Journal of rheumatology

Published: September 11, 2020

Ten years of the ESSDAI: is it fit for purpose?

Ten years of the ESSDAI: is it fit for purpose?

Journal: Clinical and experimental rheumatology

Published: June 30, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026